FDA Approved: LEVETIRACETAM — Supplemental Application (Patrin Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for the generic anticonvulsant levetiracetam from Patrin Pharma, Inc. (ANDA078582).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)